Search Results 451-460 of 17201 for egfr

1. Pioglitazone Versus Empagliflozin For Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus - Mayo Clinic

   * History of kidney dysfunction classified by eGFR of <30 mL/min/min * Participation in any clinical trial within 30 days before screening for an approved ...

2. A Study to Evaluate the Effectiveness and Safety of Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting - Mayo Clinic

   ... (eGFR) < 30 mL/min/1.73m^2 at screening or within 90 days of screening using the Schwartz formula in participants < 18 years of age. Currently breastfeeding ...

3. Endurant Stent Graft System vs Excluder Endoprothesis: A Global, Prospective, Randomized Clinical Trial in Sac Regression (ADVANCE Trial) - Mayo Clinic

   - Subject has an estimated glomerular filtration rate (eGFR) < 45 ml/min/1.73m^2 or subject is on dialysis. - Subject has a systemic infection who may be at ...

4. Study of Ociperlimab in Combination With Tislelizumab in Advanced Solid Tumors - Mayo Clinic

   Patients with any prior therapy for recurrent/metastatic disease. 2. Non-squamous NSCLC patients with sensitizing epidermal growth factor receptor (EGFR)

5. A Study to Evaluate the Effectiveness and Safety of G10 in Subjects with Transthyretin Amyloid Cardiomyopathy - Mayo Clinic

   Has estimated glomerular filtration rate (eGFR) by MDRD formula < 15 mL/min/1.73 m^2 at Screening. Known hypersensitivity to study drug (AG10 or placebo) ...

6. Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation - Mayo Clinic

   Patient with an eGFR ≤30 m/min at time of study entry. Patient with biopsy proven transplant glomerulopathy (Banff 2007 - cg score ≥2) within 2 months ...

7. An Open-Label Pilot Study of KPL-914 in Recurrent Pericarditis - Mayo Clinic

   Has an estimated glomerular filtration rate (eGFR) <30 mL/min. Has a history of malignancy of any organ system within the past 5 years (other than a ...

8. Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS) - Mayo Clinic

   ... (eGFR) \<60 ml/min/1.73m2) based on medical history, physical exam, laboratory studies, and/or electrocardiogram (ECG) performed during screening period 5 ...

9. A Study to Assess Dendritic Cell Immunotherapy Plus Standard-of-Care to Treat Advanced Renal Cell Carcinoma - Mayo Clinic

   rate (eGFR) 30 mL/min 10. Adequate hepatic function, as defined by both of the following: 1. Total serum bilirubin 1.5 x ULN 2. Aspartate aminotransferase ...

10. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    Documented EGFR activating mutations (if already tested); Prior history of other malignancy except: Basal cell carcinoma of the skin; Cervical intra ...